Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pramlintide acetate price?Novartis patent term dabrafenib?Children's ibuprofen price?The expiration date of the key patent for guselkumab?When did risperdal constas patent expire published article?
See the DrugPatentWatch profile for Ambrisentan
Ambrisentan belongs to the endothelin receptor antagonist (ERA) drug class, specifically blocking endothelin (ET) receptors in the pulmonary circulation.[1]
Endothelin is a peptide that can constrict blood vessels and contribute to vascular remodeling. By blocking endothelin receptors, endothelin receptor antagonists reduce vasoconstriction and help improve blood flow in pulmonary arteries.[1]
Ambrisentan is used to treat pulmonary arterial hypertension (PAH).[1]
Because ERAs share related mechanisms of action, they often have overlapping monitoring needs and precautions. Knowing the class helps clinicians anticipate how the drug works, how it’s likely to fit with other PAH therapies, and what risks to watch for.[1]
1
Other Questions About Ambrisentan :